The European Commission accepts commitments by Aspen to reduce prices for six off-patent cancer medicines
The European Commission has accepted commitments by Aspen to reduce the price of six critical, off-patent, cancer medicines by 73% on...
Cortex - Life Sciences Insights
About Me
Vadim Barbu has more than 9 years of expertise in the pharmaceutical sector. He is involved in novel projects in the pharmaceutical field, covering areas such as market access, managed entry agreements, pricing, reimbursement, distribution models, and patient support programs. He is also involved in advocacy activities which have an impact on shaping the market and legislative environment.
Vadim Barbu's Passles
Most Liked
Telehealth update in Romania – February 2021
Romania is one step closer to regulating telemedicine, as the draft general legal framework is now open to public debate ahead of its...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net